Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Grant symbols : Gthx save search
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-06-01 (Crawled : 21:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: -0.89%
H: 4.28%
C: 2.03%
nasdaq therapeutics grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-05-02 (Crawled : 22:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
nasdaq therapeutics grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: 0.9%
H: 0.59%
C: -1.97%
therapeutics nasdaq grant granted
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-02-01 (Crawled : 23:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -3.58%
therapeutics nasdaq grant granted
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-01-03 (Crawled : 23:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: 2.92%
H: 5.01%
C: 1.04%
therapeutics nasdaq granted grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-12-01 (Crawled : 00:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: -5.12%
H: 3.91%
C: -3.67%
therapeutics granted grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-10-01 (Crawled : 21:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
| Email alert
Add to watchlist
granted grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-09-03 (Crawled : 12:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: -1.11%
H: 1.91%
C: 0.07%
granted grant
G1 Therapeutics Granted New Technology Add-On Payment (NTAP) for COSELA™ (Trilaciclib) by Centers for Medicare & Medicaid Services (CMS)
Published: 2021-08-04 (Crawled : 20:00) - biospace.com/
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
|
| O: 0.06%
H: 2.38%
C: -0.65%
new technology technology trilaciclib granted grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-07-02 (Crawled : 00:20) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
| Email alert
Add to watchlist
granted grant nasdaq
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-06-04 (Crawled : 21:00) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
| Email alert
Add to watchlist
granted grant
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-03-05 (Crawled : 21:06) - globenewswire.com
GTHX | $3.98 -5.01% -5.28% 340K
|
Health Technology
| Email alert
Add to watchlist
granted grant
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.